NATALIE LINAHAN: Open Payments
NPI 1720530512 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,118 in 36 payments from 15 companies in 2025. Trend: 2023 $303 · 2024 $972 · 2025 $1,118
Food & beverage: $1,018Education: $100
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 7 | $331 |
| Janssen Biotech, Inc. | 5 | $251 |
| ABBVIE INC. | 5 | $102 |
| Incyte Corporation | 3 | $82 |
| Novartis Pharmaceuticals Corporation | 3 | $81 |
| LEO Pharma Inc. | 3 | $72 |
| Amgen Inc. | 2 | $29 |
| UCB, Inc. | 1 | $29 |
| Lilly USA, LLC | 1 | $25 |
| Arcutis Biotherapeutics, Inc. | 1 | $21 |
Products named: NEMLUVIO, TREMFYA, OPZELURA, ADBRY, SKYRIZI, RINVOQ, OTEZLA, Bimzelx.
Industry payments across TX — which companies pay providers there.
